奥美沙坦与药物性肠病
Olmesartan and drug-induced enteropathy.
作者信息
Tran Tran H, Li Hanlin
出版信息
P T. 2014 Jan;39(1):47-50.
Abstract
In three case histories, patients' sprue-like symptoms improved when olmesartan (Benicar) therapy was withheld.
摘要
在三个病例中，停用奥美沙坦（Benicar）治疗后，患者的口炎性腹泻样症状有所改善。
相似文献
1
Olmesartan and drug-induced enteropathy.奥美沙坦与药物性肠病
P T. 2014 Jan;39(1):47-50.
2
Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan.类脂性肠炎样肠病和肝损伤：奥美沙坦一种罕见的新出现的关联。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211037463. doi: 10.1177/23247096211037463.
3
[Olmesartan therapy and enteropathy: About two cases and review of the literature].[奥美沙坦治疗与肠病：两例病例及文献综述]
Rev Med Interne. 2019 Feb;40(2):112-116. doi: 10.1016/j.revmed.2018.08.006. Epub 2018 Aug 31.
4
Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.奥美沙坦相关的类口炎性腹泻样小肠病：一项着重于组织病理学的系统评价
Hum Pathol. 2016 Apr;50:127-34. doi: 10.1016/j.humpath.2015.12.001. Epub 2015 Dec 19.
5
An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.慢性腹泻的非典型病例：奥美沙坦诱导的类口炎性腹泻样肠病。
BMJ Case Rep. 2015 Sep 14;2015:bcr2015212318. doi: 10.1136/bcr-2015-212318.
6
Systematic review: Sprue-like enteropathy associated with olmesartan.系统评价：奥美沙坦相关类吸收不良性肠病。
Aliment Pharmacol Ther. 2014 Jul;40(1):16-23. doi: 10.1111/apt.12780. Epub 2014 May 7.
7
Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea.奥美沙坦所致肠病：一例慢性腹泻罕见病因的报告
Cureus. 2021 Aug 8;13(8):e17004. doi: 10.7759/cureus.17004. eCollection 2021 Aug.
8
Olmesartan-Induced Sprue Like Enteropathy.奥美沙坦诱导的类口炎性腹泻样小肠病。
GE Port J Gastroenterol. 2016 Jan 14;23(2):101-105. doi: 10.1016/j.jpge.2015.12.003. eCollection 2016 Mar-Apr.
9
A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan.一例与替米沙坦相关的中度类口炎性腹泻样小肠病病例。
J Clin Med Res. 2017 Dec;9(12):1022-1025. doi: 10.14740/jocmr3047w. Epub 2017 Nov 6.
10
Sprue-like enteropathy linked to olmesartan.与奥美沙坦相关的类口炎性腹泻样小肠病
Rev Esp Enferm Dig. 2016 May;108(5):292-3. doi: 10.17235/reed.2016.4140/2015.
引用本文的文献
1
Olmesartan-Associated Enteropathy: An Uncommon Cause of Chronic Diarrhea.奥美沙坦相关性肠病：慢性腹泻的罕见病因
Clin Case Rep. 2025 Jul 29;13(8):e70706. doi: 10.1002/ccr3.70706. eCollection 2025 Aug.
2
Non-Celiac Villous Atrophy-A Problem Still Underestimated.非乳糜泻性绒毛萎缩——一个仍被低估的问题。
Life (Basel). 2025 Jul 13;15(7):1098. doi: 10.3390/life15071098.
3
Atypical Rapid Onset of Olmesartan-Induced Enteropathy with Recurrence After Rechallenging.奥美沙坦诱导的肠病非典型快速发作及再次激发后复发
Diseases. 2025 Jul 18;13(7):223. doi: 10.3390/diseases13070223.
4
Olmesartan-Induced Enteropathy: When the Treatment of One Disease Causes Another.奥美沙坦所致肠病：一种疾病的治疗引发另一种疾病之时
Cureus. 2024 Feb 4;16(2):e53556. doi: 10.7759/cureus.53556. eCollection 2024 Feb.
5
Collagenous colitis associated with novel sprue-like intestinal diseases.与新型口炎性腹泻样肠道疾病相关的胶原性结肠炎。
Gastroenterol Hepatol Bed Bench. 2023;16(2):145-150. doi: 10.22037/ghfbb.v16i2.2698.
6
Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy.特鲁瓦达（替诺福韦/恩曲他滨）预先预防与乳糜泻样肠病相关。
Z Gastroenterol. 2024 Mar;62(3):404-406. doi: 10.1055/a-2079-6445. Epub 2023 May 15.
7
The histological spectrum of ARB-induced gastritis.ARB 诱导性胃炎的组织学谱。
Histopathology. 2022 Nov;81(5):653-660. doi: 10.1111/his.14766. Epub 2022 Aug 23.
8
Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions.血管紧张素 II 受体阻滞剂 (ARB) 和生产污染：一项疑似相关不良药物反应的全国登记回顾性研究。
Br J Clin Pharmacol. 2022 Nov;88(11):4812-4827. doi: 10.1111/bcp.15411. Epub 2022 Jun 8.
9
Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan.类脂性肠炎样肠病和肝损伤：奥美沙坦一种罕见的新出现的关联。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211037463. doi: 10.1177/23247096211037463.
10
Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.麸质无饮食患者的血管紧张素受体阻滞剂可能会加重乳糜泻肠病和症状。
United European Gastroenterol J. 2021 Oct;9(8):973-979. doi: 10.1002/ueg2.12117. Epub 2021 Jun 29.
本文引用的文献
1
Olmesartan-associated sprue-like enteropathy.奥美沙坦相关的口炎性腹泻样小肠病。
J Clin Gastroenterol. 2013 Nov-Dec;47(10):894-5. doi: 10.1097/MCG.0b013e31829a27e6.
2
Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma.绒毛萎缩和阴性腹腔疾病血清学：诊断和治疗困境。
Am J Gastroenterol. 2013 May;108(5):647-53. doi: 10.1038/ajg.2013.45.
3
Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea.与奥美沙坦相关的类肠病样肠病：一例罕见的严重腹泻病例
Case Rep Gastrointest Med. 2013;2013:618071. doi: 10.1155/2013/618071. Epub 2013 Mar 13.
4
Severe spruelike enteropathy associated with olmesartan.与奥美沙坦相关的严重斯普鲁样肠病。
Mayo Clin Proc. 2012 Aug;87(8):732-8. doi: 10.1016/j.mayocp.2012.06.003. Epub 2012 Jun 22.
5
The Oslo definitions for coeliac disease and related terms.奥胡斯定义：乳糜泻及相关术语
Gut. 2013 Jan;62(1):43-52. doi: 10.1136/gutjnl-2011-301346. Epub 2012 Feb 16.
6
Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation.十二指肠绒毛萎缩：实体器官移植后慢性腹泻的一个原因。
Am J Transplant. 2011 Mar;11(3):575-82. doi: 10.1111/j.1600-6143.2010.03423.x. Epub 2011 Feb 7.
7
Methotrexate induced sprue-like syndrome.甲氨蝶呤诱发口炎性腹泻样综合征。
World J Gastroenterol. 2008 Dec 7;14(45):7009-11. doi: 10.3748/wjg.14.7009.
8
Villous atrophy induced by mycophenolate mofetil in renal-transplant patients.霉酚酸酯在肾移植患者中诱导的绒毛萎缩。
Transpl Int. 2004 Sep;17(8):463-7. doi: 10.1007/s00147-004-0745-0. Epub 2004 Aug 21.
9
Severe villus atrophy and chronic malabsorption induced by azathioprine.硫唑嘌呤引起的严重绒毛萎缩和慢性吸收不良。
Gastroenterology. 2003 Jun;124(7):1950-7. doi: 10.1016/s0016-5085(03)00405-0.
10
Mechanisms of drug-induced diarrhoea in the elderly.老年人药物性腹泻的机制
Drugs Aging. 1998 Sep;13(3):245-53. doi: 10.2165/00002512-199813030-00007.
Zotero 插件